Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 1 Antiplatelet and anticoagulant pathways

Published byBrice O’Neal’ Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 1 Antiplatelet and anticoagulant pathways"— Presentation transcript:

1 Figure 1 Antiplatelet and anticoagulant pathways
Figure 1 | Antiplatelet and anticoagulant pathways. Antiplatelet and anticoagulant pathways are interrelated and each contributes to thrombosis. Antithrombotic drug combinations affect these pathways, decreasing the risk of ischaemic events, but also increasing the risk of bleeding. F, factor; GP, glycoprotein; PAR, protease-activated receptor; TF, tissue factor; TxA2, thromboxane A2. Bhatt, D. L. (2018) Advances in atherosclerosis, atrial fibrillation, and valvular disease Nat. Rev. Cardiol. doi: /nrcardio

Download ppt "Figure 1 Antiplatelet and anticoagulant pathways"

Similar presentations

Novel antithrombotic agents in acute coronary syndromes: better or worse than P2Y12 inhibitors Giuseppe Biondi Zoccai Sapienza Università di Roma

Novel antithrombotic agents in acute coronary syndromes: better or worse than P2Y12 inhibitors Giuseppe Biondi Zoccai Sapienza Università di Roma
Figure 1 Flow chart diagram of high-risk group AF patients

Figure 1 Flow chart diagram of high-risk group AF patients
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Oral Anticoagulation and Preventing Stent Thrombosis

Oral Anticoagulation and Preventing Stent Thrombosis
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
Figure 3 Metabolism pathway of antiplatelet agents

Figure 3 Metabolism pathway of antiplatelet agents
Mandeep Singh, MD, MPH, Deepak L. Bhatt, MD, MPH, Gregg W

Mandeep Singh, MD, MPH, Deepak L. Bhatt, MD, MPH, Gregg W
Figure 1 Newly discovered mechanistic pathways

Figure 1 Newly discovered mechanistic pathways
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 BMI and mortality in patients with heart failure

Figure 4 BMI and mortality in patients with heart failure
Figure 5 Two approaches to therapeutic genome editing

Figure 5 Two approaches to therapeutic genome editing
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Selecting NOACs for High-Risk Patients

Selecting NOACs for High-Risk Patients
Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Global rates of sodium, fruit, and vegetable intake
Figure 1 Mechanism of thrombus formation during ST-segment

Figure 1 Mechanism of thrombus formation during ST-segment
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
Figure 2 Size categorization of airborne pollutants

Figure 2 Size categorization of airborne pollutants

Similar presentations

Ads by Google